These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25285238)

  • 21. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
    Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
    Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 antagonist AMD3100 enhances the response of MDA-MB-231 triple-negative breast cancer cells to ionizing radiation.
    Zhou KX; Xie LH; Peng X; Guo QM; Wu QY; Wang WH; Zhang GL; Wu JF; Zhang GJ; Du CW
    Cancer Lett; 2018 Apr; 418():196-203. PubMed ID: 29317253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.
    Huang MB; Wu JY; Lillard J; Bond VC
    Oncotarget; 2019 Sep; 10(52):5419-5438. PubMed ID: 31534628
    [No Abstract]   [Full Text] [Related]  

  • 24. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
    Nautiyal J; Yu Y; Aboukameel A; Kanwar SS; Das JK; Du J; Patel BB; Sarkar FH; Rishi AK; Mohammad RM; Majumdar AP
    Mol Cancer Ther; 2010 Jun; 9(6):1503-14. PubMed ID: 20515951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
    Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
    Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.
    Yang YP; Kuo HS; Tsai HD; Peng YC; Lin YL
    Breast Cancer Res; 2005; 7(1):R19-27. PubMed ID: 15642166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
    Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
    Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.
    Labovsky V; Vallone VB; Martinez LM; Otaegui J; Chasseing NA
    Cancer Cell Int; 2012 Jun; 12(1):29. PubMed ID: 22709548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
    Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
    Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
    BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
    Xiang J; Hurchla MA; Fontana F; Su X; Amend SR; Esser AK; Douglas GJ; Mudalagiriyappa C; Luker KE; Pluard T; Ademuyiwa FO; Romagnoli B; Tuffin G; Chevalier E; Luker GD; Bauer M; Zimmermann J; Aft RL; Dembowsky K; Weilbaecher KN
    Mol Cancer Ther; 2015 Nov; 14(11):2473-85. PubMed ID: 26269605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
    Zhang MX; Han N; Yu SY; Leng Y
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
    Hassan S; Buchanan M; Jahan K; Aguilar-Mahecha A; Gaboury L; Muller WJ; Alsawafi Y; Mourskaia AA; Siegel PM; Salvucci O; Basik M
    Int J Cancer; 2011 Jul; 129(1):225-32. PubMed ID: 20830712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
    Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
    Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.
    Chinchar E; Makey KL; Gibson J; Chen F; Cole SA; Megason GC; Vijayakumar S; Miele L; Gu JW
    Vasc Cell; 2014; 6():12. PubMed ID: 24914410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
    Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
    PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
    Rahman KM; Sarkar FH; Banerjee S; Wang Z; Liao DJ; Hong X; Sarkar NH
    Mol Cancer Ther; 2006 Nov; 5(11):2747-56. PubMed ID: 17121921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.